Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.
Ataraxis has raised $20.4M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Ataraxis's investors include Founders Fund, AIX Ventures, Giant Ventures, Obvious Ventures, Floating Point.
Ataraxis is headquartered in New York, United States.
Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.
Ataraxis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ataraxis — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/ataraxis. Accessed July 19, 2026.
VCBacked. (2025). Ataraxis — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ataraxis
{{cite web |title=Ataraxis — Funding & Investors |url=https://www.vcbacked.co/company/ataraxis |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated